Cargando…

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy

AIM: To explore the role of Rac1 on sorafenib resistance in hepatocellular carcinoma. METHODS: CCK-8, wound healing assay, Transwell, and cell cycle assay were used to detect the tumor cells development. Cell viability was assessed by MTT. The glycolytic pathway was revealed by cellular metabolism a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Yin-Xiang, Li, Xiao-Bin, Liu, Wei, Yang, Xu-Guang, Liu, Xin, Luo, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279021/ https://www.ncbi.nlm.nih.gov/pubmed/35847360 http://dx.doi.org/10.1155/2022/7319641

Ejemplares similares

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Mechanism of sorafenib resistance associated with ferroptosis in HCC
por: Guo, Lingling, et al.
Publicado: (2023)

Inflammatory Mechanisms of HCC Development
por: Refolo, Maria Grazia, et al.
Publicado: (2020)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022)

Therapeutic Strategies in HCC: Radiation Modalities
por: Gallicchio, R., et al.
Publicado: (2016)

Calcium Regulates HCC Proliferation as well as EGFR Recycling/Degradation and Could Be a New Therapeutic Target in HCC
por: Modica, Teresa Maria Elisa, et al.
Publicado: (2019)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis
por: Zhao, Liang, et al.
Publicado: (2022)

miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis
por: Niu, Yaqian, et al.
Publicado: (2021)

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
por: Meng, Hongwu, et al.
Publicado: (2022)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

HCC surveillance results in earlier HCC detection: results from an Indian cohort
por: Kohli, Anita, et al.
Publicado: (2014)

Uncovering the mechanism of action of aspirin in HCC chemoprevention
por: Roehlen, Natascha, et al.
Publicado: (2019)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
por: Sun, Na, et al.
Publicado: (2020)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
por: Słomka, Artur, et al.
Publicado: (2020)

dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
por: Chu, Yen-Wei, et al.
Publicado: (2020)

The Association of HMGB1 Gene with the Prognosis of HCC
por: Xiao, Jianbiao, et al.
Publicado: (2014)

HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway
por: Chen, Lu, et al.
Publicado: (2018)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice
por: Dai, Weiqi, et al.
Publicado: (2015)

Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC
por: Ren, Zhixuan, et al.
Publicado: (2023)

Decision making in elderly HCC
por: Trovato, M A, et al.
Publicado: (2011)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

The Epigenetic Regulation of HCC Metastasis
por: Han, Tae-Su, et al.
Publicado: (2018)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

HCC diagnosis DFP report
Publicado: (2021)

Diabetes medications and risk of HCC
por: Plaz Torres, Maria Corina, et al.
Publicado: (2022)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?
por: Khanam, Arshi, et al.
Publicado: (2022)

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
por: Ito, Takanori, et al.
Publicado: (2023)

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC
por: Zhou, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qpngqcbgpaf6r988sg65be7jn2